期刊文献+

RVVC患者阴道分泌物中SP-A的表达及意义 被引量:3

Expression and Signification of Pulmonary Surfactant-associated Protein-A in the Vaginal Fluid of Vulvovaginal Candidiasis
下载PDF
导出
摘要 旨在探讨肺表面活性物质相关蛋白A(SP-A)在复发性外阴阴道假丝酵母菌病(RVVC)患者阴道分泌物中的表达及意义。收集RVVC患者、外阴阴道假丝酵母菌患者(VVC)及健康体检者(对照组)阴道分泌物各20例,用酶联免疫吸附测定法(ELISA)测定各组中SP-A蛋白的含量,用逆转录聚合酶链式反应(RT-PCR)方法检测各组中SP-A的基因表达情况。用ELISA方法检测各组中SP-A蛋白的含量发现,VVC组的SP-A明显高于对照组(P<0.05),RVVC组的SP-A高于对照组及VVC组(P<0.05)。RT-PCR检测结果发现,VVC组的SP-A mRNA的表达水平高于对照组(P<0.05),RVVC组的SP-AmR-NA的表达水平明显高于对照组及VVC组(P<0.05)。SP-A可能是RVVC患者抗假丝酵母菌的重要物质,其性质或数量的改变可能在RVVC的发病机制中发挥重要作用。 It was to study the expression and signification of pulmonary surfactant-associated protein-A in the vaginal fluid of recurrent vulvovaginal candidiasis(RVVC). Human vaginal fluid from 20 RVVC patients,20 VVC patients and 20 healthy women( the control group)were collected,respectively. Enzyme-linked immunosorbent assay (ELISA)was applied to detect the levels of SP-A. The expression of SP-A gene was detected by reverse transcription polymerase chain reaction (RT-PCR). Results indicated that the levels and of SP-A of VVC group were higher than that of the control group( P 〈 0.05 ). The levels of SP-A of recurrent vulvovaginal candidiasis(RVVC) group were higher than those of VVC group and control group,and the expression of SP-A mRNA in VVC was higher than that in the control group. The expression of SP-A mRNA in RVVC was significantly higher than those of VVC group and control group. Therefore,SP-A might be an essential component in RVVC resistance. The qualitative and quantitative alterations of normal SP-A may play a role in the pathogenesis of RVVC.
作者 明燕虹 袁瑞
出处 《生物技术通报》 CAS CSCD 北大核心 2010年第2期145-148,共4页 Biotechnology Bulletin
关键词 外阴阴道念珠菌病 肺表面活性物质相关蛋白A 基因表达 Vulvovaginal candidiasis Pulmonary surfactant-associated protein-A Gene expression
  • 相关文献

参考文献9

二级参考文献41

  • 1肖燕,崔社怀.肺表面活性蛋白A在免疫炎症反应中的作用[J].免疫学杂志,2000,16(z1):102-105. 被引量:5
  • 2祁文瑾,石一复.念珠菌性外阴阴道炎的免疫学研究[J].国外医学(妇幼保健分册),2004,15(4):214-216. 被引量:14
  • 3牛战琴,石一复,吕时铭,叶红.阴道上皮细胞的抗念珠菌作用及雌激素对此的影响[J].现代妇产科进展,2004,13(6):416-418. 被引量:12
  • 4马沛然.肺表面活性物质治疗呼吸窘迫综合征临床应用进展[J].山东医药,1994,34(3):48-49. 被引量:1
  • 5Fleury FJ. Adult vaginitis. Clin Obstet Gynecol, 1981, 24: 407-438.
  • 6Sobel JD. Pathogenesis and epidemiology of vulvovaginal candidiasis. Ann N Y Acad Sci,1988, 544: 547-557.
  • 7Fidel PL Jr, Ginsburg KA, Cutright JL, et al.Vaginal-associated immunity in women with recurrent vulvovaginal candidiasis: evidence for vaginal Th1-type responses following intravaginal challenge with Candida antigen.J Infect Dis, 1997, 176: 728-739.
  • 8Weissenbacher S, Witkin SS, Tolbert V, et al. Value of Candida polymerase chain reaction and vaginal eytokine analysis for the differential diagnosis of women with recurrent vulvovaginitis. Infect Dis Obstet Gynecol, 2000, 8: 244-247.
  • 9Fratti RA,Ghannoum MA,Edwards JE Jr,et al.Gamma interferon protects endothelial cells from damage by Candida albicans by inhibiting endothelial cell phagocytosis.Infect Immun,1996,64:4714-4718.
  • 10Clift RA.Candidiasis in the transplant patient.Am J Med,1984,77:34-38.

共引文献67

同被引文献29

  • 1祁文瑾,石一复.念珠菌性外阴阴道炎的免疫学研究[J].国外医学(妇幼保健分册),2004,15(4):214-216. 被引量:14
  • 2罗乐,何于江,周章武.He-Ne激光和CO_2激光针灸的研究[J].激光杂志,1996,17(1):43-47. 被引量:17
  • 3刘朝晖,王晓莉,廖秦平.外阴阴道假丝酵母菌病患者阴道局部免疫环境状态研究[J].中华妇产科杂志,2006,41(12):843-844. 被引量:48
  • 4Foxman B, Muraglia R, Dietz JP, et al. Prevalence of recurrent vul- vovaginal candidiasis in 5 european countries and the united states:results from an internet panel survey[ J]. J Low Genit Tract Dis,2013,17(3) :340-5.
  • 5Weissenbaeher TM, Witkin SS, Gingel maier A, et al. Relationship between recurrent vulvovaginal caudidosis and immune mediators in vaginal fluid[J]. Eur J Obstet Gynecol Reprod Biol,2009,144 ( 1 ) :59-63.
  • 6Fidel PL Jr, Barousse M, Espinosa T, et al. An intravaginal live candid challenge in humans leads to new hypotheses for the immu- nopathogenesis of vulvovaginal candidiasis [ J ]. Infect Immun, 2004,72 ( 5 ) :2939-2946.
  • 7Amouri I, Hadrich I, Abbes S, et al. Local humoral immunity in vulvovaginal candidiasis [ J ] . Ann Biol Clin ( Paris ) , 2013,71 (2) :151-155.
  • 8Sandini S, La Valle R, Deaglio S, et al. A highly immunogenic re- combinant and truncated protein of the secreted aspartic proteases family (rSap2t) of Candida albicans as a mucosal anticandidal vaccine[ J]. Immunol Med Microbio1,2011,62 ( 2 ) :215-224.
  • 9Donders GG, Mertens I, Bellen G,et al. Self-elimination of risk factors for recurrent vaginal candidosis [ J ]. Mycoses, 2011,54 ( 1 ):39-45.
  • 10SPacek J, Buehta V, Jilek P, et al. Clinical aspect and luteal Phase assessment in Patients with recurrent vulvovaginal candidiasis [ J ] . Eur J Obstet Gynecol Reprod Biol, 2007, 131 (2) :198-202.

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部